Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Bristol-Myers Squibb
 More »

  • GEN's List of Molecular Millionaires
    seven, followed by Vertex Pharmaceuticals (four); Bio-Rad Laboratories and Danaher (three each); and Bristol-Myers Squibb, Life Technologies, and Mettler Toledo (two each). ...
    10-15-2013
  • Lilly Peers Into Future, Sees Three Drug Launches in 2014
    ... These drugs, according to Lilly, "could form the basis for a regulatory submission as early as 2014." In January, Lilly revealed it lost Bristol-Myers Squibb as a partner in ...
    10-3-2013
  • FDA Speeds Things Up
    Bristol-Myers Squibb, Genentech, Amplimmune, and CureTech all similarly have drugs directed at either PD-1 or its ligand. But, according to Dr. Hamid, the lambrolizumab antibody is ...
    10-1-2013
  • GEN Publishes Its Top 40 Molecular Millionaires List
    (NASDAQ:VRTX, four), Bio-Rad Laboratories and Danaher, three each, and Bristol-Myers Squibb (NYSE:BMY), Life Technologies (NASDAQ:LIFE), and Mettler Toledo (NYSE:MTD), two ...
    9-25-2013
  • GEN Reports on Downfall of a Once Biotech King
    Referring to his family's role in helping to engineer the $300 million takeover of Genetic Systems by Bristol-Myers Squibb, he noted that, because of that deal, "The Blechs became ...
    9-20-2013
  • Top 40 Molecular Millionaires
    seven, followed by Vertex Pharmaceuticals (four), Bio-Rad Laboratories and Danaher (three each), and Bristol-Myers Squibb, Life Technologies, and Mettler Toledo (two each). ...
    9-19-2013
  • JobWatch: Praying for a Massachusetts Miracle
    ... The employee number remains unknown, Bayer HealthCare spokeswoman Susan Yarin told GEN. Bristol-Myers Squibb: Room to Grow in Florida Bristol-Myers Squibb announced a specific site ...
    9-18-2013
  • Empire Crumbles for a Once Biotech King
    ... According to Blech, Genetic Systems eventually went public in 1981 with a valuation of $20 million. It was sold five years later to Bristol Myers Squibb for $300 million. "That ...
    9-18-2013
  • BMS Licenses PeptiDream Technology, Extends Collaboration
    PeptiDream said today it agreed to license nonexclusively its Peptide Discovery Platform System (PDPS) technology to Bristol-Myers Squibb (BMS), as well as to a second extension of ...
    9-17-2013
  • Otsuka Acquires Astex for $866M
    (OPC-14597) co-marketed with Bristol-Myers Squibb, expires in 2015. Otsuka also said the acquisition will strengthen its portfolio of drug candidates and treatments for cancer. ...
    9-5-2013
  • FDA Speeds Things Up
    Bristol-Myers Squibb, Genentech, Amplimmune, and CureTech all similarly have drugs directed at either PD-1 or its ligand. But, according to Hamid, the lambrolizumab antibody is the ...
    9-3-2013
  • Executive VP at AbbVie Tops GEN List as Highest Paid Woman in...
    in second was Beatrice Cazala, executive vp of commercial operations at Bristol-Myers Squibb (NYSE:BMY), with a total 2012 compensation of $8,031,025, according to GEN . "Our ...
    8-14-2013
  • Vical Scraps Melanoma Candidate After Phase III Failure
    (IND) pending with FDA. Vaxfectin adjuvant has been licensed by Vical to Bristol-Myers Squibb for production of antibodies, and to vaccine developer Cyvax for malaria ...
    8-12-2013
  • JobWatch: What Price BMS Jobs? $6,000 (and More)
    Thermo Fisher is eliminating 655 jobs as Life Tech purchase looms. The Sunshine State's warming up to Bristol-Myers Squibb (BMS). Florida's Hillsborough County will spend $6,000 ...
    8-7-2013
  • Novartis, Ensemble Therapeutics Launch Collaborations
    Those partners include Alexion Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, and Pfizer. One collaboration focuses on IL-17 antagonists; the other uses ...
    8-6-2013

  • Journal Articles

  • Hypolipidemic and Antioxidant Potentials of Xylopia aethiopica...
    Sarah O. Nwozo, Bosede F. Orojobi, Oluwatosin A. Adaramoye
    Journal of Medicinal Food
    .../kg/0.3?mL, plant extracts at 250?mg/kg, and cholestyramine (Questran®, Bristol-Myers Squibb, Hounslow, United Kingdom) at 0.26?g/kg five times a week for 8 consecutive weeks. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll